Search details
1.
Advances in desensitization for human leukocyte antigen incompatible kidney transplantation.
Curr Opin Organ Transplant
; 29(2): 104-120, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38088373
2.
A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.
Kidney Int
; 103(1): 187-195, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36332728
3.
Importance of IL-6 inhibition in prevention and treatment of antibody-mediated rejection in kidney allografts.
Am J Transplant
; 22 Suppl 4: 28-37, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36453709
4.
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.
Am J Transplant
; 22(4): 1133-1144, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34910841
5.
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.
Clin Transplant
; 36(8): e14734, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35657013
6.
Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimus.
Transpl Infect Dis
; 24(2): e13805, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35213773
7.
Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients.
Transpl Infect Dis
; 24(2): e13813, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35202497
8.
Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes.
J Am Soc Nephrol
; 32(2): 397-409, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33323474
9.
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.
Am J Transplant
; 21(12): 3907-3918, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34236770
10.
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
Clin Infect Dis
; 71(12): 3168-3173, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-32575124
11.
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab.
Am J Transplant
; 20(9): 2581-2588, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32301258
12.
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection.
Am J Transplant
; 20 Suppl 4: 42-56, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32538536
13.
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
N Engl J Med
; 377(5): 442-453, 2017 08 03.
Article
in English
| MEDLINE | ID: mdl-28767349
14.
Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
Am J Transplant
; 19(6): 1663-1670, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30725531
15.
Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy.
Am J Transplant
; 19(2): 381-390, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29981209
16.
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.
Am J Transplant
; 19(11): 3035-3045, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31257724
17.
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System.
Am J Kidney Dis
; 73(5): 605-614, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30929853
18.
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
Am J Transplant
; 18(12): 2955-2964, 2018 12.
Article
in English
| MEDLINE | ID: mdl-29637714
19.
Update on the use of immunoglobulin in human disease: A review of evidence.
J Allergy Clin Immunol
; 139(3S): S1-S46, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-28041678
20.
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Kidney Int
; 91(3): 729-737, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28104301